Explore
Validate
Learn
Western blot
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Flow cytometry [1]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-12476 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- CAR Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 400 µL
- Concentration
- 2 mg/mL
- Storage
- Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Submitted references Chimeric oncolytic Ad5/3 virus replicates and lyses ovarian cancer cells through desmoglein-2 cell entry receptor.
Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse model.
Kuryk L, Møller AW
Journal of medical virology 2020 Aug;92(8):1309-1315
Journal of medical virology 2020 Aug;92(8):1309-1315
Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse model.
Kuryk L, Møller AW, Jaderberg M
Oncoimmunology 2019;8(2):e1532763
Oncoimmunology 2019;8(2):e1532763
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Flow cytometry analysis of NCI-H460 cells using a CXADR polyclonal antibody (Product # PA5-12476) (bottom), compared to a negative control cell (top) at a dilution of 1:10-50, followed by a FITC-conjugated goat anti-rabbit antibody
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 1 EOC receptor expression and sensitivity to oncolytic activity to ONCOS-102 treatment. A, Flow cytometry analyses of CAR, CD46, and DSG2 receptor expression on ovarian cancer cells. At least 10 4 events were analyzed for each marker and cell line. Results represent the mean +- SEM of at least two independent experiments. Cell viability at (B) 72 hours or (C) 96 hours after ONCOS-102 treatment in five different concentrations was assessed with the MTS assay. Results are expressed as the mean percent of untreated cells +- SEM. Data represents a pool of two independent experiments run in triplicate. CAR, coxsackie and adenovirus receptor; DSG2, desmoglein-2; EOC, epithelial ovarian cancer
